Nurix Therapeutics (NRIX) Change in Receivables (2023)

Nurix Therapeutics (NRIX) reported Change in Receivables of -$2.0 million for Q4 2023, down 200.0% quarter-over-quarter from $2.0 million in Q3 2023.

Nurix Therapeutics (NRIX) Change in Receivables (2023) Analysis & Trends

Nurix Therapeutics (NRIX) has 1 years of Change in Receivables data on file, last reported at -$2.0 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Receivables (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	22,529.00
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-39.80 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	-4.08 Mn
10	Nurix Therapeutics	1.93 Bn	1.39 Bn	-	-

Download Data